Lucas Buchanan
About Lucas Buchanan
Lucas Buchanan is the Chief Financial Officer and Chief Operating Officer at Silk Road Medical, Inc., and serves on the boards of Endologix LLC and CRG LP. He has extensive experience in marketing, business development, and corporate strategy within the healthcare sector.
Company
Lucas Buchanan currently works at Silk Road Medical, Inc. as the Chief Financial Officer and Chief Operating Officer, based in Sunnyvale, California. He is also actively involved with Endologix LLC as a Board Member and serves on the Strategic Advisory Board for CRG LP Fund V.
Title
Lucas Buchanan holds the dual roles of Chief Financial Officer and Chief Operating Officer at Silk Road Medical, Inc. He also contributes his expertise as a Board Member at Endologix LLC and as a Strategic Advisory Board Member with CRG LP Fund V.
Education and Expertise
Lucas Buchanan has an extensive educational background, holding a B.A. in Economics from Duke University and an M.B.A. in Health Care Management from The Wharton School at the University of Pennsylvania. His expertise spans across various facets of healthcare and financial management, with significant experience in marketing, business development, and corporate strategy.
Professional Background
Lucas Buchanan has held multiple senior roles at Silk Road Medical, Inc., including Vice President of Marketing and Business Development, Executive Vice President, and now, Chief Financial Officer & Chief Operating Officer. Prior to this, he was an Executive in Residence at Warburg Pincus LLC in San Francisco, focusing on healthcare investments. He also served as Senior Director of Strategy and Corporate Development at Impax Laboratories.
Achievements
During his tenure at The Vertical Group, Lucas Buchanan played a pivotal role in leading investments in healthcare companies such as Atheromed and Lutonix, both of which were acquired by larger corporations. He also contributed significantly to the early development and financing milestones of Silk Road Medical while at The Vertical Group. In his early career, he advised healthcare companies on M&A transactions and financing at Ernst & Young Corporate Finance.